Search for: "In Re Data General Corp. Antitrust Litigation" Results 61 - 80 of 99
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2024, 6:52 am by Daniel J. Gilman
Justice Department’s (DOJ) Antitrust Division, and a former FTC general counsel. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
21 Nov 2008, 1:36 pm
(Financial Aspects of Intellectual Property) Climate change and Millenium Development Goals top agenda during UN Secretary General’s visit to WIPO (WIPO) Global - Trade Marks / Brands What every marketing department needs to know about trade marks (IP Spotlight) Forbes 2008 list of ‘Top-earning Dead Celebrities’ (Seattle Trademark Lawyer) Trade mark protection, broadcast rights vital for sports, say stakeholders (Intellectual Property Watch) How many drafts… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
1 Jul 2015, 7:34 am by Schachtman
Statisticians create and use a variety of materials that are clearly relevant to the their opinion: programs and programming code run to generate all specified analyses on specified data, statistical packages, all data available, all data “cleaning” or data selection processes, selection of variables from those available, data frames that show what data were included (and excluded) in the analyses, data input files,… [read post]
18 Mar 2010, 2:47 pm by Beck, et al.
General Motors Corp., 463 F.2d 98, 100 (2d Cir. 1972) (“bare bones statement. . .without any supporting facts permits dismissal”); Jackson v. [read post]
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog)   Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in… [read post]
13 Sep 2007, 10:48 am
That's due to Bexis' involvement in that litigation. [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
5 Sep 2008, 11:01 pm
: (Excess Copyright), (Michael Geist), Opinion and analysis of C-61: (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), 61 reforms to C-61: (Day 50: Education harms – lessons contain limited definition of students – Michael Geist), (Day 51: Education internet exception is unnecessary – Michael Geist), (Day 52: Education internet exception is harmful – Michael Geist), (Day 53: Education internet exception… [read post]
1 Jan 2023, 12:58 pm by D. Casey Flaherty
Root causes can be difficult to communicate and even more difficult to hear, but they’re also the ground floor of virtually all sustainable solutions. [read post]